Sasaki S, Shibata N, Iwata M
Department of Neurology, Neurological Institute, Tokyo Women's Medical College, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.
Acta Neuropathol. 2001 Apr;101(4):351-7. doi: 10.1007/s004010000282.
We investigated the spinal cords of 15 patients with sporadic amyotrophic lateral sclerosis (ALS) immunohistochemically using an anti-human neuronal nitric oxide synthase (nNOS) antibody to examine whether there is increased nNOS immunoreactivity in anterior horn neurons. Specimens from 16 patients without any neurological disease served as controls. In the controls, nNOS immunoreactivity of large anterior horn neurons was detected in 10 out of 16 cases. However, there were few nNOS-positive neurons, and most of large anterior horn neurons were spared. In the ALS patients, the mean number of nNOS-positive anterior horn neurons per transverse section of L4 and L5 was significantly larger (16.2 +/- 10.9) than that in the controls (7.0 +/- 9.2) (P < 0.0001). Moreover, 41.4% of large anterior horn neurons in ALS showed nNOS immunoreactivity in remarkable contrast to 7.6% in the controls. All ALS patients, whether showing mild, moderate or severe depletion of anterior horn neurons, displayed a higher percentage of nNOS-positive anterior horn neurons than the control patients showing nNOS immunoreactivity (P < 0.01). Most of the remaining anterior horn neurons in ALS showed more intense nNOS immunoreactivity on the surface of the neurons and their neuronal processes compared with the controls. Degenerated anterior horn neurons frequently demonstrated more intense nNOS immunoreactivity on the surface of the neurons than normal-appearing neurons. Some anterior horn cells displayed nNOS immunoreactivity in the somata. Dot-like nNOS deposits on anterior horn neurons were also positively immunoreactive with anti-synaptophysin antibody. Thus, increased nNOS expression is located mainly at the synaptic sites on the anterior horn neurons in sporadic ALS, which may be related to the degeneration of anterior horn neurons in this disease. Further studies are needed to determine whether the increased nNOS immunoreactivity plays a neuroprotective or neurotoxic role in the anterior horn neurons, and to show nitric oxide production in ALS.
我们使用抗人神经元型一氧化氮合酶(nNOS)抗体,对15例散发性肌萎缩侧索硬化症(ALS)患者的脊髓进行免疫组织化学研究,以检查前角神经元中nNOS免疫反应性是否增加。16例无任何神经疾病的患者的标本作为对照。在对照组中,16例中有10例检测到大型前角神经元的nNOS免疫反应性。然而,nNOS阳性神经元很少,大多数大型前角神经元未受影响。在ALS患者中,L4和L5每横切面nNOS阳性前角神经元的平均数量(16.2±10.9)明显多于对照组(7.0±9.2)(P<0.0001)。此外,ALS中41.4%的大型前角神经元显示nNOS免疫反应性,与对照组的7.6%形成显著对比。所有ALS患者,无论前角神经元是轻度、中度还是重度缺失,其nNOS阳性前角神经元的百分比均高于显示nNOS免疫反应性的对照患者(P<0.01)。与对照组相比,ALS中其余大多数前角神经元在神经元及其神经突起表面显示出更强的nNOS免疫反应性。与外观正常的神经元相比,退化的前角神经元在神经元表面经常显示出更强的nNOS免疫反应性。一些前角细胞在胞体中显示nNOS免疫反应性。前角神经元上的点状nNOS沉积物也与抗突触素抗体呈阳性免疫反应。因此,散发性ALS中nNOS表达增加主要位于前角神经元的突触部位,这可能与该疾病中前角神经元的退化有关。需要进一步研究以确定nNOS免疫反应性增加在前角神经元中是发挥神经保护还是神经毒性作用,并显示ALS中一氧化氮的产生情况。